Should we screen for prostate cancer? A re-examination of the evidence

Med J Aust. 2013 Jun 3;198(10):525-7. doi: 10.5694/mja12.11576.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Decision Support Techniques
  • Early Detection of Cancer* / adverse effects
  • Early Detection of Cancer* / methods
  • Humans
  • Kallikreins / blood*
  • Male
  • Patient Participation
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnosis*
  • Risk Assessment
  • Unnecessary Procedures

Substances

  • Biomarkers
  • KLK3 protein, human
  • Kallikreins
  • Prostate-Specific Antigen